Allergan has entered into an agreement with a subsidiary of Covidien, under which Covidien will co-promote Allergan's Lap-Band adjustable gastric banding system to bariatric and other surgeons in the US.
Subscribe to our email newsletter
Under the multi-year agreement, which became effective on November 9, 2007, Covidien will leverage its expertise in bariatrics and utilize its surgical devices sales force to promote the Lap-Band system. Allergan will continue to deploy its own bariatric sales force and recognize revenues from the sale of the Lap-Band system.
The Lap-Band system was developed to facilitate long-term weight loss and reduce the health risks associated with severe and morbid obesity.
Robert Grant, president of Allergan Medical, a division of Allergan, said: “The alliance with Covidien is an important step in the fight against obesity. With a strong investment in targeted consumer advertising, comprehensive surgeon and referring physician education and robust reimbursement assistance, we are successfully broadening patient awareness of and access to the Lap-Band system, as evidenced by the market leadership and rapid growth of the product.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.